NDC 69452-0156-73
rizatriptan benzoate 5 mg/1 TABLET, ORALLY DISINTEGRATING
Available — 2-Day Shipping
NDC
69452-0156-73
Generic Name
rizatriptan benzoate
Brand Name
RIZATRIPTAN BENZOATE
Strength
5 mg/1
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Package Size
—
Labeler
Bionpharma Inc.,
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE Rizatriptan Benzoate Orally Disintegrating Tablets are indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years old. Limitations of Use Rizatriptan benzoate orally disintegrating tablets should only be used where a clear diagnosis of migraine has been established. If a patient has no response for the first migraine attack treated with rizatriptan benzoate orally disintegrating tablets, USP, the diagnosis of migra…
Source: FDA. For professional use only. Not a substitute for prescribing information.
View Product Detail →
See full specifications, request 2-day shipping, and create account to view pricing
All rizatriptan benzoate Strengths & Forms →
Compare all available NDC codes, strengths, and manufacturers
Other rizatriptan benzoate NDC Codes
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 69452-0156-73 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).